World's Best Scientists 2026 revealed!
Toshifumi Hibi

Toshifumi Hibi

Award Badge
Medicine
Japan
2023

D-Index & Metrics

Medicine

D-Index
115
Citations
50077
World Ranking
4531
National Ranking
98

Toshifumi Hibi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Toshifumi Hibi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,255 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Toshifumi Hibi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Toshifumi Hibi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 115 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Japan Leader Award

Overview

Toshifumi Hibi is affiliated with Kitasato University in Japan and has an extensive publication record primarily in the field of medicine. Their research focuses on inflammatory bowel diseases and related areas within gastroenterology, genetics, and molecular biology.

The major fields of study in which Toshifumi Hibi has contributed include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields of study encompass:

  • Genetics
  • Epidemiology
  • Surgery
  • Gastroenterology
  • Oncology

The primary research topics addressed in their work involve:

  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Eosinophilic Esophagitis
  • Helicobacter pylori-related gastroenterology studies
  • Autoimmune and Inflammatory Disorders
  • Celiac Disease Research and Management
  • Liver Diseases and Immunity

Toshifumi Hibi has frequently published in the following venues:

  • Gastroenterology
  • The American Journal of Gastroenterology
  • Journal of Crohn's and Colitis
  • Intestinal Research
  • Inflammatory Intestinal Diseases

Among notable recent papers associated with or relevant to their research include:

  • Ulcerative colitis, 2020, published in Nature Reviews Disease Primers
  • Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial, 2021, published in The Lancet
  • Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials, 2021, published in Gastroenterology
  • Transperineal ultrasound predicts endoscopic and histological healing in ulcerative colitis, 2020, published in Alimentary Pharmacology & Therapeutics
  • Accuracy of Ultrasound for Evaluation of Colorectal Segments in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis, 2020, published in Clinical Gastroenterology and Hepatology

Frequent co-authors working alongside Toshifumi Hibi include:

  • Taku Kobayashi
  • Remo Panaccione
  • Alison Potts Bleakman
  • Theresa Hunter
  • Simon Travis

Best Publications

  • Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011

    Hisanori Umehara;Kazuichi Okazaki;Yasufumi Masaki;Mitsuhiro Kawano

  • Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.

    William J Sandborn;Brian G Feagan;Colleen W Marano;Hongyan Zhang

  • A pilot randomized Trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease

    Hiroaki Ito;Masakazu Takazoe;Yoshihiro Fukuda;Toshifumi Hibi

  • Unique CD14+ intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-γ axis

    Nobuhiko Kamada;Tadakazu Hisamatsu;Susumu Okamoto;Hiroshi Chinen

  • IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s disease

    Taku Kobayashi;Susumu Okamoto;Tadakazu Hisamatsu;Nobuhiko Kamada

  • Development of the Crohn's disease digestive damage score, the Lémann score†‡§

    Benjamin Pariente;Jacques Cosnes;Silvio Danese;William J. Sandborn

  • Lack of common NOD2 variants in Japanese patients with Crohn's disease

    Nagamu Inoue;Kazuo Tamura;Yoshitaka Kinouchi;Yoshihiro Fukuda

  • Evidence-based clinical practice guidelines for inflammatory bowel disease

    Katsuyoshi Matsuoka;Taku Kobayashi;Fumiaki Ueno;Toshiyuki Matsui

  • A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis

    Haruhiko Ogata;Toshiyuki Matsui;Makoto Nakamura;Mitsuo Iida

  • Damaged epithelia regenerated by bone marrow–derived cells in the human gastrointestinal tract

    Ryuichi Okamoto;Tomoharu Yajima;Motomi Yamazaki;Takanori Kanai

  • Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice

    Kengo Tomita;Gen Tamiya;Satoshi Ando;Kayoko Ohsumi

  • Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion.

    Jing-Yan Han;Jing-Yu Fan;Yoshinori Horie;Soichiro Miura

  • Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health

    Laurent Peyrin-Biroulet;Alarcos Cieza;Alarcos Cieza;William J. Sandborn;Michaela Coenen;Michaela Coenen

  • Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease.

    Hiromasa Takaishi;Takahiro Matsuki;Atsushi Nakazawa;Toshihiko Takada

  • A Single Strain of Clostridium butyricum Induces Intestinal IL-10-Producing Macrophages to Suppress Acute Experimental Colitis in Mice

    Atsushi Hayashi;Toshiro Sato;Nobuhiko Kamada;Yohei Mikami

  • Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice.

    Kengo Tomita;Toshiaki Teratani;Takahiro Suzuki;Motonori Shimizu

  • Interleukin 7 Transgenic Mice Develop Chronic Colitis with Decreased Interleukin 7 Protein Accumulation in the Colonic Mucosa

    Mamoru Watanabe;Yoshitaka Ueno;Tomoharu Yajima;Susumu Okamoto

  • Prevalence of ulcerative colitis and Crohn’s disease in Japan

    Keiko Asakura;Yuji Nishiwaki;Nagamu Inoue;Toshifumi Hibi

  • Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

    Brian G. Feagan;Silvio Danese;Edward V. Loftus;Séverine Vermeire

  • Animal models of inflammatory bowel disease.

    Toshifumi Hibi;Haruhiko Ogata;Atsushi Sakuraba

Frequent Co-Authors

Hidekazu Suzuki
Hidekazu Suzuki Tokai University
Takanori Kanai
Takanori Kanai Keio University
Mamoru Watanabe
Mamoru Watanabe Tokyo Medical and Dental University
Hiromasa Ishii
Hiromasa Ishii Keio University
Nobuhiko Kamada
Nobuhiko Kamada University of Michigan–Ann Arbor
Toshiro Sato
Toshiro Sato Keio University
Yuji Naito
Yuji Naito Kyoto Prefectural University of Medicine
Shinji Tanaka
Shinji Tanaka Hiroshima University
Hiroshi Hosoda
Hiroshi Hosoda Shinshu University
Masaki Kitajima
Masaki Kitajima Keio University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in pursuing Medicine in the USA, there are numerous related healthcare degrees and career options available online. These pathways offer flexibility for students with demanding schedules or those balancing work and family commitments.

For those looking to advance their nursing careers, consider exploring cheapest online acute care nurse practitioner programs. These programs prepare you for high-demand roles in acute care settings without breaking the bank. If you’re just starting out or seeking foundational knowledge, a variety of online nursing courses offer convenient learning options in core subjects and specializations.

Nurses aiming for leadership, research, or academic roles should look into earning an online phd in nursing. These programs enable you to influence the future of healthcare while maintaining your current responsibilities. For registered nurses, the rn to bsn cheapest options provide a budget-friendly path to a bachelor's degree, which can open doors to more job opportunities and career advancement.

Exploring these online degrees can help you tailor your education to your career goals while keeping costs manageable.

Best Scientists Citing Toshifumi Hibi

Trending Scientists

Recently Published Articles